FDA Approves Phases II and IIa Clinical Trial of L-SerineSee links to FDA-approved Phase II clinical trial of L-serine for ALS patients and Phase IIa clinical trial of L-serine for early stage Alzheimer's patients

FDA Approves Phases I and IIa Clinical Trials of L-Serine for ALS, early-stage Alzheimer's Disease, and mild cognitive impairment.

What is L-serine?

Click to learn more about how L-serine affects our day-to-day lives.

L-serine.png

L-Serine Safe for ALS Patients.

We completed a Phase I ALS trial (to demonstrate the safety of the naturally occurring amino acid, L-serine, in humans) that showed encouraging signs of slowing disease progression among enrolled patients.

Ogimi

L-Serine's Potential for ALS Patients.

Ogimi Village is Renowned for its Aging Population. We sought to determine if the L-serine content of their diet could account for their neurological health.

See our L-serine research papers here.